Stability Testing of Drug Products

Focus: EU and ICH Requirements

Author: Dr Helmut Vigenschow

Navigate the latest stability testing topics related to drug products with this comprehensive overview on the regulatory requirements during product development and lifecycle. This includes aspects covered by the new draft ICH Q1 guideline. This resource clarifies regulatory expectations for marketing authorisation applications, covering essential topics like accelerated testing conditions, shelf-life determination, climatic zone requirements, and stability commitments. Understand how to design compliant studies, interpret results, and prepare CTD documentation effectively. A practical reference for pharmaceutical professionals seeking current guidance to support regulatory submissions and ensure compliance.

Download now the white paper 'Stability Testing of Drug Products – Focus: EU and ICH Requirements'.

We wish you many valuable insights as you read.